KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EPS (Basic): 2009-2024

Historic EPS (Basic) for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $0.16.

  • Incyte's EPS (Basic) rose 294.55% to $2.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.04, marking a year-over-year increase of 3452.94%. This contributed to the annual value of $0.16 for FY2024, which is 94.01% down from last year.
  • Latest data reveals that Incyte reported EPS (Basic) of $0.16 as of FY2024, which was down 94.01% from $2.67 recorded in FY2023.
  • Over the past 5 years, Incyte's EPS (Basic) peaked at $4.30 during FY2021, and registered a low of -$1.36 during FY2020.
  • Moreover, its 3-year median value for EPS (Basic) was $1.53 (2022), whereas its average is $1.45.
  • As far as peak fluctuations go, Incyte's EPS (Basic) crashed by 165.38% in 2020, and later spiked by 416.18% in 2021.
  • Incyte's EPS (Basic) (Yearly) stood at -$1.36 in 2020, then surged by 416.18% to $4.30 in 2021, then plummeted by 64.42% to $1.53 in 2022, then spiked by 74.51% to $2.67 in 2023, then slumped by 94.01% to $0.16 in 2024.